Targeting post-translational histone modifying enzymes in glioblastoma.
Pharmacol Ther. 2021 Apr;220:107721. doi: 10.1016/j.pharmthera.2020.107721. Epub 2020 Nov 2.
Pharmacol Ther. 2021.
PMID: 33144118
Review.